proxyvotesnow.com

Home › Companies › agilon health, inc. › 2025-2026

agilon health, inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and agilon health, inc.’s Form 8-K, filed 2026-06-03 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 7Ballot items
  • 133Asset managers
  • 1,073Fund votes
  • 2026-06-02Main meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore agilon health, inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by agilon health, inc.

These tallies are agilon health, inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-03 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. agilon health, inc. reported 2 meetings in this season; each is tabulated separately below, with its own filing.

agilon health, inc. — official shareholder meeting results, meeting held 2026-06-02 (Form 8-K, filed 2026-06-03)
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Diana McKenzie 11,679,958177,7607,034 --1,870,677 Majority: yes
Elect Director: Karen McLoughlin 9,525,4912,332,2087,053 --1,870,677 Majority: yes
Elect Director: Ronald Williams 10,837,6231,019,3477,782 --1,870,677 Majority: yes
Proposal 2: Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. 13,712,3686,61616,445 ---- Majority: yes
Proposal 3: Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers. 11,228,258627,8708,624 --1,870,677 Majority: yes

Source: agilon health, inc., Form 8-K, filed with the SEC on 2026-06-03 — read the filing on EDGAR.

agilon health, inc. — official shareholder meeting results, meeting held 2026-03-17 (Form 8-K, filed 2026-03-18)
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Proposal 1: Approval of Reverse Stock Split The stockholders approved an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-fiv 356,574,7896,187,388365,864 ---- Majority: yes
Proposal 2: Approval of Adjournment of the Special Meeting The stockholders approved the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes i 350,802,13511,672,713653,193 ---- Majority: yes

Source: agilon health, inc., Form 8-K, filed with the SEC on 2026-03-18 — read the filing on EDGAR.

How asset managers voted at the agilon health, inc. 2025-2026 meetings

Each item below shows how the 133 asset managers that disclosed a agilon health, inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Approval, by advisory vote, of the compensation paid to the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2026-06-02.

Combines 6 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 11,228,258AGAINST: 627,870

agilon health, inc.’s own tally for this item (“Proposal 3: Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers.”): 11,228,258 for, 627,870 against, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 414,869,759 outstanding shares: 3% for, 0.2% against (3% of the company cast a for/against vote).

The 132 asset managers below cast 93% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 92%
FOR: 91.5%AGAINST: 6.6%ABSTAIN: 1.9%
Largest asset managers voting on “Approval, by advisory vote, of the compensation paid to the Company's named executive officers.” at agilon health, inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Clayton, Dubilier & Rice, LLC4,000,0000 00For
Morgan Stanley2,539,2120 00For
North Peak Capital Management, LLC1,009,5510 00For
Vanguard807,950572 00For
BlackRock744,32792 00For
Charles Schwab0729,585 00Against
AQR489,5010 00For
DE Shaw437,6730 00For
Fidelity269,1700 00For
GEODE CAPITAL MANAGEMENT, LLC266,1270 00For
Rock Springs Capital Management LP260,0000 00For
Rubicon Founders LLC00 251,6950Abstain
JACOBS LEVY EQUITY MANAGEMENT, INC222,3320 00For
Goldman Sachs175,7490 00For
Equitable157,3180 00For
Eversept Partners, LP149,3110 00For
State Street113,62948 00For
Brighthouse105,1370 1,2610For
Amundi078,772 00Against
Northern Lights Fund Trust IV64,0810 00For
Northern Trust56,4620 00For
Renaissance43,7310 00For
Nuveen36,4730 00For
CANADA PENSION PLAN INVESTMENT BOARD33,5040 00For
Lazard28,4560 00For

Showing the 25 largest of 132 asset managers. See all 132 in the interactive database.

2. Election of Class II Directors: Diana McKenzie

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-02.

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 11,679,958AGAINST: 177,760

agilon health, inc.’s own tally for this item (“Elect Director: Diana McKenzie”): 11,679,958 for, 177,760 against, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 414,869,759 outstanding shares: 3% for, 0.1% against (3% of the company cast a for/against vote).

The 48 asset managers below cast 99.5% of the shares they voted on this item FOR (2,946,368 for, 11,919 against).

FOR 99.5%
FOR: 2,946,368 (99.6%)AGAINST: 11,919 (0.4%)ABSTAIN: 1,266 (0.0%)
Largest asset managers voting on “Election of Class II Directors: Diana McKenzie” at agilon health, inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Morgan Stanley789,9590 00For
Vanguard718,1330 00For
Charles Schwab364,7790 00For
BlackRock354,9270 00For
Fidelity265,5190 00For
Equitable148,9298,389 00For
Brighthouse105,1370 1,2610For
Northern Lights Fund Trust IV64,0810 00For
TIAA26,5640 00For
PACE SELECT ADVISORS TRUST15,6010 00For
Goldman Sachs9,3400 00For
Lincoln Financial8,344660 00For
AQR8,3260 00For
Global X7,3780 00For
Simplify Exchange Traded Funds6,3130 00For
AIG/SunAmerica6,2510 00For
Russell Investments6,1540 00For
Nuveen4,4770 00For
Pacific Life4,0300 00For
John Hancock3,6020 00For
Saba Capital Income & Opportunities Fund3,43377 40For
Bridge Builder Trust2,4200 00For
CLEARWATER INVESTMENT TRUST2,4000 00For
Dimensional02,041 00Against
ProShares1,9070 00For

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

3. Election of Class II Directors: Karen McLoughlin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-02.

Combines 6 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%AGAINST 20%
FOR: 9,525,491AGAINST: 2,332,208

agilon health, inc.’s own tally for this item (“Elect Director: Karen McLoughlin”): 9,525,491 for, 2,332,208 against, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 414,869,759 outstanding shares: 2% for, 0.6% against (3% of the company cast a for/against vote).

The 48 asset managers below cast 92% of the shares they voted on this item FOR (2,708,429 for, 249,858 against).

FOR 92%8%
FOR: 2,708,429 (91.5%)AGAINST: 249,858 (8.4%)ABSTAIN: 1,266 (0.0%)
Largest asset managers voting on “Election of Class II Directors: Karen McLoughlin” at agilon health, inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Morgan Stanley789,467492 00For
Vanguard639,91378,220 00For
Charles Schwab364,7790 00For
BlackRock354,9270 00For
Fidelity223,28742,232 00For
Equitable148,9298,389 00For
Brighthouse100,9074,230 1,2610For
Northern Lights Fund Trust IV64,0810 00For
TIAA026,564 00Against
PACE SELECT ADVISORS TRUST015,601 00Against
Goldman Sachs09,340 00Against
Lincoln Financial09,004 00Against
AQR08,326 00Against
Global X07,378 00Against
Simplify Exchange Traded Funds6,3130 00For
AIG/SunAmerica06,251 00Against
Russell Investments06,154 00Against
Nuveen04,477 00Against
Pacific Life4,0300 00For
John Hancock03,602 00Against
Saba Capital Income & Opportunities Fund2,557952 40For
Bridge Builder Trust2,4200 00For
CLEARWATER INVESTMENT TRUST02,400 00Against
Dimensional02,041 00Against
ProShares01,907 00Against

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

4. Election of Class II Directors: Ronald Williams

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2026-06-02.

Combines 5 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%9%
FOR: 10,837,623AGAINST: 1,019,347

agilon health, inc.’s own tally for this item (“Elect Director: Ronald Williams”): 10,837,623 for, 1,019,347 against, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 414,869,759 outstanding shares: 3% for, 0.3% against (3% of the company cast a for/against vote).

The 48 asset managers below cast 86% of the shares they voted on this item FOR (2,543,472 for, 414,815 against).

FOR 86%AGAINST 14%
FOR: 2,543,472 (85.9%)AGAINST: 414,815 (14.0%)ABSTAIN: 1,267 (0.0%)
Largest asset managers voting on “Election of Class II Directors: Ronald Williams” at agilon health, inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Morgan Stanley789,9590 00For
Vanguard698,11620,017 00For
Charles Schwab364,7790 00For
BlackRock0354,927 00Against
Fidelity265,5190 00For
Equitable129,11928,199 00For
Brighthouse105,1370 1,2610For
Northern Lights Fund Trust IV64,0810 00For
TIAA26,5640 00For
PACE SELECT ADVISORS TRUST15,6010 00For
Goldman Sachs9,3400 00For
Lincoln Financial8,344660 00For
AQR8,3260 00For
Global X7,3780 00For
Simplify Exchange Traded Funds6,3130 00For
AIG/SunAmerica6,2510 00For
Russell Investments6,1540 00For
Nuveen4,4770 00For
Pacific Life04,030 00Against
John Hancock3,6020 00For
Saba Capital Income & Opportunities Fund3,41099 40For
Bridge Builder Trust02,420 00Against
CLEARWATER INVESTMENT TRUST2,4000 00For
Dimensional02,041 00Against
ProShares1,9070 00For

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

5. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2026-06-02.

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 13,712,368AGAINST: 6,616

agilon health, inc.’s own tally for this item (“Proposal 2: Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ”): 13,712,368 for, 6,616 against, per its Form 8-K filed 2026-06-03 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 414,869,759 outstanding shares: 3% for, 0.1% against (3% of the company cast a for/against vote).

The 48 asset managers below cast 99.9% of the shares they voted on this item FOR (2,958,283 for, 4 against).

FOR 99.9%
FOR: 2,958,283 (100.0%)AGAINST: 4 (0.0%)ABSTAIN: 1,266 (0.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING” at agilon health, inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Morgan Stanley789,9590 00For
Vanguard718,1330 00For
Charles Schwab364,7790 00For
BlackRock354,9270 00For
Fidelity265,5190 00For
Equitable157,3180 00For
Brighthouse105,1370 1,2610For
Northern Lights Fund Trust IV64,0810 00For
TIAA26,5640 00For
PACE SELECT ADVISORS TRUST15,6010 00For
Goldman Sachs9,3400 00For
Lincoln Financial9,0040 00For
AQR8,3260 00For
Global X7,3780 00For
Simplify Exchange Traded Funds6,3130 00For
AIG/SunAmerica6,2510 00For
Russell Investments6,1540 00For
Nuveen4,4770 00For
Pacific Life4,0300 00For
John Hancock3,6020 00For
Saba Capital Income & Opportunities Fund3,5063 40For
Bridge Builder Trust2,4200 00For
CLEARWATER INVESTMENT TRUST2,4000 00For
Dimensional2,0410 00For
ProShares1,9070 00For

Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.

6. Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-five, with the exact ratio to be set within this range by the Board of Directors in its sole discretion (without reducing the authorized number of shares of the Company's common stock) (the "Amendment

CAPITAL STRUCTUREMajority of the votes cast: yes

Meeting held 2026-03-17.

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 356,574,789AGAINST: 6,187,388

agilon health, inc.’s own tally for this item (“Proposal 1: Approval of Reverse Stock Split The stockholders approved an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a rat”): 356,574,789 for, 6,187,388 against, per its Form 8-K filed 2026-03-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 414,869,759 outstanding shares: 86% for, 1% against (87% of the company cast a for/against vote).

The 43 asset managers below cast 99.9% of the shares they voted on this item FOR (77,805,469 for, 4 against).

FOR 99.9%
FOR: 77,805,469 (100.0%)AGAINST: 4 (0.0%)ABSTAIN: 31,549 (0.0%)
Largest asset managers voting on “Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a revers” at agilon health, inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Morgan Stanley19,841,8490 00For
Vanguard17,317,5224 00For
Fidelity9,027,3400 00For
Charles Schwab8,414,2810 00For
BlackRock7,658,0300 00For
Brighthouse7,147,7660 31,5490For
Equitable3,933,0150 00For
Invesco816,2180 00For
TIAA660,0700 00For
PACE SELECT ADVISORS TRUST309,5640 00For
Goldman Sachs301,0000 00For
Lincoln Financial250,7280 00For
Nationwide231,7310 00For
Simplify Exchange Traded Funds182,5850 00For
Global X175,2390 00For
AIG/SunAmerica156,2880 00For
Northern Trust130,5680 00For
Nuveen111,9340 00For
State Street109,7200 00For
Pacific Life108,7040 00For
MASTER INVESTMENT PORTFOLIO97,9000 00For
John Hancock96,0590 00For
CLEARWATER INVESTMENT TRUST77,1820 00For
ProShares62,2010 00For
Bridge Builder Trust60,5180 00For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

7. APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES, IF NECESSARY, TO PERMIT FURTHER SOLICITATION AND VOTE OF PROXIES IN THE EVENT THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF THE AMENDMENT PROPOSAL.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Meeting held 2026-03-17.

97% Majority: yes · of votes cast

FOR 97%
FOR: 350,802,135AGAINST: 11,672,713

agilon health, inc.’s own tally for this item (“Proposal 2: Approval of Adjournment of the Special Meeting The stockholders approved the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in th”): 350,802,135 for, 11,672,713 against, per its Form 8-K filed 2026-03-18 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 414,869,759 outstanding shares: 85% for, 3% against (87% of the company cast a for/against vote).

The 43 asset managers below cast 99.4% of the shares they voted on this item FOR (78,050,499 for, 401,726 against).

FOR 99.4%
FOR: 78,050,499 (99.4%)AGAINST: 401,726 (0.5%)ABSTAIN: 31,549 (0.0%)
Largest asset managers voting on “APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES, IF NECESSARY, TO PERMIT FURTHER S” at agilon health, inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Morgan Stanley19,841,8490 00For
Vanguard17,317,5224 00For
Fidelity9,027,3400 00For
Charles Schwab8,414,2810 00For
BlackRock7,658,0300 00For
Brighthouse7,147,7660 31,5490For
Equitable3,933,0150 00For
Invesco816,2180 00For
Northern Lights Fund Trust IV723,9340 00For
TIAA660,0700 00For
PACE SELECT ADVISORS TRUST309,5640 00For
Goldman Sachs301,0000 00For
Lincoln Financial16,528234,200 00Against
Nationwide231,7310 00For
Simplify Exchange Traded Funds182,5850 00For
Global X175,2390 00For
AIG/SunAmerica156,2880 00For
Northern Trust130,5680 00For
Nuveen111,9340 00For
State Street0109,720 00Against
Pacific Life108,7040 00For
MASTER INVESTMENT PORTFOLIO97,9000 00For
John Hancock96,0590 00For
ProShares62,2010 00For
Bridge Builder Trust60,5180 00For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

Largest agilon health, inc. shareholders voting in 2025-2026

Ranked by the number of agilon health, inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 414,869,759 shares outstanding at the time of that meeting.

Top agilon health, inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Clayton, Dubilier & Rice, LLC 0.96%
2Morgan Stanley 0.61%
3North Peak Capital Management, LLC 0.24%
4Vanguard 0.19%
5BlackRock 0.18%
6Charles Schwab 0.18%
7AQR 0.12%
8DE Shaw 0.11%
9Fidelity 0.06%
10GEODE CAPITAL MANAGEMENT, LLC 0.06%

Reported agilon health, inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

agilon health, inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
The Vanguard Group 4.42% 13G
CD&R Vector Holdings, L.P. 0.96% DEF14A
Morgan Stanley 0.48% DEF14A
North Peak Capital Management, LLC 0.38% DEF14A
Goldman Sachs 0.26% 13F
BlackRock 0.21% 13F
D.E. Shaw 0.18% 13F
Charles Schwab 0.09% 13F
Geode Capital 0.06% 13F
State Street 0.06% 13F

Percentages above are of 414,869,759 shares outstanding, as reported by agilon health, inc. on its Form 10-K dated 2026-02-19 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from agilon health, inc.’s 10-K dated 2026-02-19. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At agilon health, inc.'s 2 shareholder meetings in the 2025-2026 proxy season (held 2026-03-17 and 2026-06-02), 133 asset managers reported how they voted on 7 ballot items in their SEC Form N-PX filings, covering 1,073 separate fund positions. On the most widely held item of the season, voted at the meeting held 2026-06-02 — Approval, by advisory vote, of the compensation paid to the Company's named executive officers. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: agilon health, inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-03.

agilon health, inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).